Metacognitive Therapy for Obsessive-Compulsive Disorder
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Behavioral: Metacognitive TherapyOther: General mental health promotion
- Registration Number
- NCT06466057
- Lead Sponsor
- Northeast Normal University
- Brief Summary
The goal of this clinical trial is to learn if metacognitive therapy can be effective in a Chinese sample of obsessive compulsive disorder (OCD) . The main questions it aims to answer are:
Can metacognitive therapy significantly reduce participants' levels of obsessive-compulsive symptoms? Can metacognitive therapy significantly improve participants' metacognitive adaptations?
The researchers will compare metacognitive therapy to a control condition without psychotherapy to see if metacognitive therapy is effective in treating OCD.
Participants will:
Receive the metacognitive therapy intervention or under control conditions for 8 to 15 weeks.
Be assessed for symptoms and metacognitive beliefs at pre-intervention, post-intervention and 12 weeks post-intervention
- Detailed Description
This study will be a randomised controlled clinical trial. Participants who meet the enrolment criteria will be randomised into an experimental group and a control group. Participants in the experimental group will receive 8-15 weeks of metacognitive therapy, while participants in the control group will receive the same amount of time of regular treatment without psychotherapy components.
The researchers will assess participants' obsessive-compulsive symptoms and metacognitive levels before, after, and 12 weeks after the intervention. Assessment measures will be the Yale Brown Obsessive-Compulsive Scale (Y-BOCS) and the Metacognition Questionnaire (MCQ-30).
By comparing the assessment results of the two groups of participants, conclusions will be drawn as to whether metacognitive therapy can have a positive effect on a Chinese OCD sample.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 80
- two psychiatrists with the title of Deputy Chief Physician or above jointly determine that the above diagnostic criteria were met
- education level of junior high school or above, without mental retardation or audio-visual disorders
- participation in the study is voluntary, and the informed consent is signed by the patient or his/her guardian
- loss of or insufficient self-awareness, the presence of hallucinations, delusions, and other psychotic symptoms
- the presence of severe depression, or self-inflicted suicidal attempts and behaviors
- the presence of a history of alcohol or drug abuse
- refusal of psychotherapy, or the ineffectiveness of those who had been involved in a full course of psychotherapy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Metacognitive Therapy Metacognitive Therapy Intervention using metacognitive therapy, with sessions set for 8-15 weeks of 1-2 weekly psychotherapeutic dialogue. Control Condition General mental health promotion Do not receive any additional psychotherapy in addition to conventional treatment.
- Primary Outcome Measures
Name Time Method Severity of participants' obsessive-compulsive symptoms Pre-intervention to 12 weeks post-intervention Assessed using the Yale Brown Obsessive-Compulsive Scale (Y-BOCS) , with higher scores indicating more severe symptoms.
- Secondary Outcome Measures
Name Time Method Levels of Participants' Dysfunctional Metacognitive Beliefs Pre-intervention to 12 weeks post-intervention Assessed using the Metacognition Questionnaire (MCQ-30), with higher scores being associated with more dysfunctional metacognition.
Trial Locations
- Locations (1)
Northeast Normal University
🇨🇳Changchun, Jilin, China